Recruiting Neuropathy Studies in Fresno
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. ...
About Neuropathy Clinical Trials in Fresno
Neuropathy refers to damage or dysfunction of peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet. Diabetes is the most common cause, but it can also result from infections, injuries, and autoimmune conditions. Treatment focuses on managing the underlying cause and pain relief.
There are currently 2 neuropathy clinical trials recruiting participants in Fresno, CA. These studies are seeking a combined 1,550 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuropathy Clinical Trials in Fresno — FAQ
Are there neuropathy clinical trials in Fresno?
Yes, there are 2 neuropathy clinical trials currently recruiting in Fresno, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fresno?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fresno research site will contact you about next steps.
Are clinical trials in Fresno free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fresno studies also compensate for your time and travel.
What neuropathy treatments are being tested?
The 2 active trials in Fresno are testing new therapies including novel drugs, biologics, and treatment approaches for neuropathy.
Data updated March 2, 2026 from ClinicalTrials.gov